Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd M Morgan

Showing results (231-240 of 307) with videos related to

Pageof 31
Sort By:
The Journal of Urology|January 18, 2020
Reply by AuthorsJeannette M Schenk, Lisa F Newcomb, Yingye Zheng, et al.
European Urology|January 8, 2018
Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall SurvivalWilliam C Jackson, Krithika Suresh, Vasu Tumati, et al.
European Urology Open Science|August 2, 2021
Association of Urinary MyProstateScore, Age, and Prostate Volume in a Longitudinal Cohort of Healthy Men: Long-term Findings from the Olmsted County StudyJeffrey J Tosoian, Rodney L Dunn, Yashar S Niknafs, et al.
World Journal of Urology|May 19, 2015
Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinomaGeorgios Gakis, Todd M Morgan, Jason A Efstathiou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2020
17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) CohortDaniel W Lin, Yingye Zheng, Jesse K McKenney, et al.
Urology|July 19, 2021
Initial Findings from a High Genetic Risk Prostate Cancer ClinicMichael S Sessine, Sanjay Das, Bumsoo Park, et al.
The Journal of Urology|October 26, 2019
African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance StudyJeannette M Schenk, Lisa F Newcomb, Yingye Zheng, et al.
Medical Oncology (Northwood, London, England)|February 15, 2021
De novo neuroendocrine transdifferentiation in primary prostate cancer-a phenotype associated with advanced clinico-pathologic features and aggressive outcomeEman Abdulfatah, Zachery R Reichert, Matthew S Davenport, et al.
European Urology Oncology|May 18, 2019
Impact of Biochemical Failure After Salvage Radiation Therapy on Prostate Cancer-specific Mortality: Competition Between Age and Time to Biochemical FailureWilliam C Jackson, Krithika Suresh, Vasu Tumati, et al.
European Urology Focus|July 30, 2017
Programmed Death-ligand 1 Expression in Upper Tract Urothelial CarcinomaStephanie L Skala, Tzu-Ying Liu, Aaron M Udager, et al.
Pageof 31

Showing results (231-240 of 307) with videos related to

Sort By:
Pageof 31
The Journal of Urology|January 18, 2020
Reply by AuthorsJeannette M Schenk, Lisa F Newcomb, Yingye Zheng, et al.
European Urology|January 8, 2018
Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall SurvivalWilliam C Jackson, Krithika Suresh, Vasu Tumati, et al.
European Urology Open Science|August 2, 2021
Association of Urinary MyProstateScore, Age, and Prostate Volume in a Longitudinal Cohort of Healthy Men: Long-term Findings from the Olmsted County StudyJeffrey J Tosoian, Rodney L Dunn, Yashar S Niknafs, et al.
World Journal of Urology|May 19, 2015
Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinomaGeorgios Gakis, Todd M Morgan, Jason A Efstathiou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2020
17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) CohortDaniel W Lin, Yingye Zheng, Jesse K McKenney, et al.
Urology|July 19, 2021
Initial Findings from a High Genetic Risk Prostate Cancer ClinicMichael S Sessine, Sanjay Das, Bumsoo Park, et al.
The Journal of Urology|October 26, 2019
African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance StudyJeannette M Schenk, Lisa F Newcomb, Yingye Zheng, et al.
Medical Oncology (Northwood, London, England)|February 15, 2021
De novo neuroendocrine transdifferentiation in primary prostate cancer-a phenotype associated with advanced clinico-pathologic features and aggressive outcomeEman Abdulfatah, Zachery R Reichert, Matthew S Davenport, et al.
European Urology Oncology|May 18, 2019
Impact of Biochemical Failure After Salvage Radiation Therapy on Prostate Cancer-specific Mortality: Competition Between Age and Time to Biochemical FailureWilliam C Jackson, Krithika Suresh, Vasu Tumati, et al.
European Urology Focus|July 30, 2017
Programmed Death-ligand 1 Expression in Upper Tract Urothelial CarcinomaStephanie L Skala, Tzu-Ying Liu, Aaron M Udager, et al.
Pageof 31